Thyrocare
Technologies Ltd (500312) closes at ₹1448.05 with
a Gain of +6.20% on
25-June-2021 with formation of a Long green Candle on Daily
Price Chart.
About the Company : Thyrocare is the largest B2B player
in the diagnostics space and has a network of over 3,330 collection centres
across 2,000 towns in India. It operates a multi-lab model with 1 mega central
processing lab, two zonal processing labs and 13 regional processing labs
across the country.
Sector Update : India’s ehealth sector reached about $1.4
billion GMV in 2020 and is expected to grow around 10 times over the period of
CY20-25. The industry is expected to grow its GMV by $11-15 billion by CY25.
Financials : Thyrocare
Technologies Ltd has posted Net Sales / Revenue of ₹494.60 Cr & Net Profit
of ₹113.10 Cr in FY2021 and expected to post Net Sales /
Revenue of ₹564.30Cr & Net Profit of ₹141.90 Cr in FY2022 & Net Sales / Revenue of ₹635.60 Cr & Net
Profit of ₹164.00 Cr in FY2023 and Net Sales / Revenue of ₹741.30 Cr & Net
Profit of ₹183.30 Cr in FY2024.
EPS will be improved from 21.4
in FY2021 to 31.50 in FY2023 & 20.40 in FY2023, Free Cash Flow will
increase from ₹88.00 Cr to ₹172.50Cr during the same period. Book Value Per Share will increase from
₹80.80 to ₹92.0 in FY2023
& RoA will increase to 24.6% by
FY2023.
Valuations :
The Company is now Trading at X 4.10 of its valuations of its FY2021 earnings with ~310% Premium
and X3.24 of its FY2022 earnings with ~224% Premium & X2.80 of its FY2023
earnings with ~180% premium and X2.51of
its FY2024 earnings with ~151% premium.
Margin
of Safety (1Yr Bond Yield: Value>1 ) is now
0.40 which makes is attractive after ~60% dip in price.
The Equity Value Per Share ( Enterprise Value Method ) is ₹1445.10
If We factor its FY2024 earnings/valuations, its Price
arrives at ₹2368 (without
considering PharmEasy).
Market Sentiment Update : Our Nifty Next Indictor (NNI) is
now at 120.04 as on 25-June-2021, which suggests the Return on Equity
Investment will be 8.4% in next 6Month; 1.7% in 12M & -5.0% (Negative) in 24M(
Based on Historical data).
Disclaimer : We are / may going to take exposure shortly.
Join Us at Telegram
# https://t.me/TheNiftyNext
Data Source | NSE Website | Screener.In | Capital Line | Money Control |
The
author tracks economic, behavioural and corporate tends, hoping to gauge good
avenues of return based on Fundamental Valuations of Stocks, a follower of EPV
method. You can reach me/us at |
Twitter # NiftyNext1 | e-Mail :
Mail@NiftyNext.Com | Tel +91
8802230836 | Telegram # TheNiftyNext |
Manage your
investments the right way With
MProfit. Visit https://www.mprofit.in/
Use Our Referral Link
to Get 20% DISCOUNT @ https://www.mprofit.in/buy?referral=R1GD99J496AB1345D